View Older Stories View More Recent Stories
-
Orosur Announces That Its Brokered LIFE Private Placement is Oversubscribed and Fully Allocated
-
Strive Enterprises (ASST) Reiterated at Buy by StoneX on Launch of Digital Credit ETF
-
XCF Global reports $10M+ August revenue from 1.3M gallons of renewable diesel
-
X-energy's TRISO-X president Joel Duling to retire in November
-
Quantum Cyber narrows strategy to three defense tech pillars
-
Standard Uranium Announces AGM Results and Granting of Compensation Securities
-
Last Chance to See Hunt Slonem's Through the Looking Glass at One Art Space
-
Vinland Closes First Tranche of Flow-Through Financing
-
XCF Global (NASDAQ:SAFX) Announces August Revenue of More Than $10 Million From Shipment of 1.3M Gallons of Renewable Fuel
-
Bernstein SocGen sees downside risk to Apple's December quarter gross margin and EPS
-
Alibaba (BABA) Reiterated at Buy by StoneX as AI Flywheel Strengthens
-
Costco Wholesale (COST) PT Lowered to $1,015 at JPMorgan
-
JPMorgan Positive on Birkenstock (BIRK): '“clean” FY27 set-up for the first time in 3 years', 'our work points to above-algorithm opportunity in FY27'
-
TD Cowen Reiterates Buy Rating on Costco Wholesale (COST)
-
Craig-Hallum Starts TELA Bio, Inc. (TELA) at Buy
-
Acadia Pharmaceuticals (ACAD) PT Lowered to $35 at Needham
-
Porch Group Inc. (PRCH) PT Raised to $20 at Cantor Fitzgerald on Execution on Key Growth Pillars
-
HB Fuller (FUL) PT Lowered to $65 at Baird
-
Nektar wins $90M verdict against Eli Lilly in contract dispute
-
McDonald's (MCD) PT Lowered to $250 at Baird
-
Ocugen gets provisional approval in Bahamas for RP gene therapy OCU400
-
Aurora Innovation (AUR) Reiterated at Overweight by Cantor Fitzgerald - Leader in Autonomous Trucks
-
Hovde Group Starts Park National (PRK) at Market Perform
-
FDA grants priority review to AstraZeneca's Imfinzi combo for bladder cancer
-
Legend Biotech reports 50% of myeloma patients progression-free at 5 years
-
Atlas Energy Solutions signs power equipment deals with AI lab
-
Reborn Coffee signs non-binding MOU with Visvita for RTD and supply
-
Fate Therapeutics gets $15M CIRM grant for lupus nephritis trial
-
Libra Energy to Participate in CEM's Muskoka Capital Event
-
Buffalo Potash Completes Final Horizontal Well and Concludes Successful Drilling Program
-
Sirios Begins Drilling at the Aquilon Gold Project in Eeyou Istchee James Bay, Quebec
-
American Hotel Income Properties REIT LP Announces Corporate Update
-
UraniumX Plans Winter Gravity Program at Murphy Lake as Q4 Assays Approach
-
Core Silver Announces Grant of Stock Options
-
ATA Critical Event Services Expands From Three Partners to a Network of More Than 20
-
White Gold Corp. Announces Filing of Preliminary Economic Assessment with C$1.86 Billion After-Tax NPV, 41% IRR and 1.5 Year Payback Period on the White Gold Project, Yukon, Canada
-
Why stocks held up despite rising yields and $100 oil? These 2 words explain it
-
Stock action shows confidence in central banks: BofA’s Hartnett
-
Meta Platforms Inc. (META) PT Raised to $950 at Canaccord
-
BlackBerry (BB) PT Lowered to $9.50 at Canaccord
-
H.C. Wainwright Reiterates Buy Rating on Coya Therapeutics (COYA)
-
H.C. Wainwright Reiterates Buy Rating on Abeona Therapeutics (ABEO)
-
H.C. Wainwright Reiterates Buy Rating on Enanta Pharmaceuticals (ENTA)
-
Surrozen Inc. (SRZN) PT Raised to $54 at H.C. Wainwright
-
H.C. Wainwright Reiterates Buy Rating on Kyverna Therapeutics Inc (KYTX)
-
H.C. Wainwright Reiterates Buy Rating on Ultragenyx Pharma (RARE)
-
H.C. Wainwright Reiterates Buy Rating on Axsome Therapeutics (AXSM)
-
Zscaler (ZS) PT Raised to $220 at Mizuho
-
Pelican AI to Attend Sibos 2026 in Miami to Advance Global Banking Relationships
-
GRAIL, Inc. (GRAL) PT Raised to $100 at Mizuho
